Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Malherbe

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Plos Pathogens|June 11, 2024
Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagationPaige Fletcher, Chad S Clancy, Kyle L O'Donnell, et al.
Journal of Virology|August 15, 2014
Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1D Noah Sather, Sara Carbonetti, Delphine C Malherbe, et al.
Journal of Virology|March 9, 2018
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus ChallengesAnn J Hessell, Mariya B Shapiro, Rebecca Powell, et al.
Journal of Virology|March 25, 2011
Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodiesDelphine C Malherbe, Nicole A Doria-Rose, Lynda Misher, et al.
NPJ Vaccines|July 23, 2021
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, et al.
Emerging Microbes & Infections|July 20, 2023
Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infectionPaige Fletcher, Kyle L O'Donnell, Brianna M Doratt, et al.
Nature Communications|February 17, 2022
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccinesSvenja Weiss, Vincenza Itri, Ruimin Pan, et al.
Journal of Virology|September 12, 2014
Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbitsDelphine C Malherbe, Franco Pissani, D Noah Sather, et al.
The Journal of Infection|October 12, 2025
Age-related severity of nontuberculous mycobacterial lung disease is mediated by aberrant macrophage responses and lung microbial dysbiosisEthan G Napier, Brianna M Doratt, Isaac R Cinco, et al.
Journal of Virology|December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus VaccineJ Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Plos Pathogens|June 11, 2024
Pathogenic differences of cynomolgus macaques after Taï Forest virus infection depend on the viral stock propagationPaige Fletcher, Chad S Clancy, Kyle L O'Donnell, et al.
Journal of Virology|August 15, 2014
Emergence of broadly neutralizing antibodies and viral coevolution in two subjects during the early stages of infection with human immunodeficiency virus type 1D Noah Sather, Sara Carbonetti, Delphine C Malherbe, et al.
Journal of Virology|March 9, 2018
Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus ChallengesAnn J Hessell, Mariya B Shapiro, Rebecca Powell, et al.
Journal of Virology|March 25, 2011
Sequential immunization with a subtype B HIV-1 envelope quasispecies partially mimics the in vivo development of neutralizing antibodiesDelphine C Malherbe, Nicole A Doria-Rose, Lynda Misher, et al.
NPJ Vaccines|July 23, 2021
A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19Delphine C Malherbe, Drishya Kurup, Christoph Wirblich, et al.
Emerging Microbes & Infections|July 20, 2023
Single-dose VSV-based vaccine protects cynomolgus macaques from disease after Taï Forest virus infectionPaige Fletcher, Kyle L O'Donnell, Brianna M Doratt, et al.
Nature Communications|February 17, 2022
Differential V2-directed antibody responses in non-human primates infected with SHIVs or immunized with diverse HIV vaccinesSvenja Weiss, Vincenza Itri, Ruimin Pan, et al.
Journal of Virology|September 12, 2014
Envelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbitsDelphine C Malherbe, Franco Pissani, D Noah Sather, et al.
The Journal of Infection|October 12, 2025
Age-related severity of nontuberculous mycobacterial lung disease is mediated by aberrant macrophage responses and lung microbial dysbiosisEthan G Napier, Brianna M Doratt, Isaac R Cinco, et al.
Journal of Virology|December 7, 2018
Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus VaccineJ Brian Kimble, Delphine C Malherbe, Michelle Meyer, et al.
Pageof 6